QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 timber-pharmaceuticals-inc-files-for-voluntary-chapter-11-bankruptcy-timber-pharmaceuticals-inc-lists-both-assets-and-liabilities-in-range-of-1m-10m

- Court Filing

 timber-pharmaceuticals-says-proposal-to-approve-merger-agreement-was-not-approved-by-a-majority-of-outstanding-shares-of-common-stock-entitled-to-vote-held-special-meeting-to-vote-on-matters-like-adopt-plan-of-merger-with-leo-us-leo-spiny-merger-sub

- SEC Filing

 hc-wainwright--co-downgrades-timber-pharmaceuticals-to-neutral

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Timber Pharmaceuticals (AMEX:TMBR) from Buy to Neutral.

 crude-oil-falls-nikola-shares-plummet

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow t...

 why-super-league-gaming-are-trading-lower-by-around-46-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33.

 dow-tumbles-over-100-points-timber-pharmaceuticals-shares-spike-higher

U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 100 points on Monday. The Dow traded dow...

 us-stocks-mostly-higher-nasdaq-jumps-100-points

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday. Following the...

 why-timber-pharmaceuticals-stock-is-skyrocketing-today

Timber Pharmaceuticals, Inc. (NYSE: TMBR) has 

 timber-pharmaceuticals-to-present-interim-analyses-from-phase-3-ascend-study-of-tmb-001-in-congenital-ichthyosis

- First Presentation of Data From Phase 3 ASCEND Study Will Feature Pharmacokinetic Results That Indicate Minimal Systemic Abso...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION